Article | August 10, 2022

How A Decentralized Clinical Trial Model Can Enhance Diversity In Oncology Research

Source: THREAD

By Esther Howard, Oncology Advisor, THREAD

gettyimages-1356442521-170667a

When a patient is first diagnosed with cancer, their entire world changes. Fear and anxiety immediately set in because so much is unknown. They worry about their treatment options, their quality of life and how long they have left to live. Their friends and family are affected.  Fortunately, however, research is bringing new treatment options to patients every day.

The main difference between oncology research and every other therapeutic research area is that for a cancer patient, a clinical trial is the only option left after standard of care options are exhausted. The unfortunate fact is that most cancer patients still do not have access to clinical trials as further hope for treatment because of where they live.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader